Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127917771 | 12791777 | 1 | I | 20160919 | 20160929 | 20160929 | EXP | GB-MHRA-ADR 23644560 | GB-TEVA-694974ACC | TEVA | 47.00 | YR | F | Y | 0.00000 | 20160929 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127917771 | 12791777 | 1 | PS | DOXYCYCLINE. | DOXYCYCLINE | 1 | 100 MILLIGRAM DAILY; LONG TERM USE. | Y | U | 62031 | 100 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127917771 | 12791777 | 1 | Lower respiratory tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127917771 | 12791777 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127917771 | 12791777 | Asthenia | |
| 127917771 | 12791777 | Eye pain | |
| 127917771 | 12791777 | Facial paralysis | |
| 127917771 | 12791777 | Fatigue | |
| 127917771 | 12791777 | Headache | |
| 127917771 | 12791777 | Ocular hyperaemia | |
| 127917771 | 12791777 | Somnolence | |
| 127917771 | 12791777 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |